How Technology is Streamlining Clinical Trials
One can witness noteworthy changes in the way clinical trials are executed in the present day. The adoption of innovative technologies has put patients at the forefront of the clinical research process. This advancement has resulted in amplified awareness among people, a drop in the overall patient recruitment time, and ultimately lessen the cost of conducting clinical trials.
In brief, technology has made the researchers’ jobs quicker and more streamlined while saving a substantial amount of time for all parties involved.
Technological Advancements Making Patient Data Monitoring Easier
In today’s data-driven world, patient data forms the most critical factor in clinical decision-making process. Capturing and monitoring the patient’s data has become quite more accessible because of the advancement of mobile and wearable technologies. These technologies are considered to be a great source of automated patient monitoring. It helps the clinical research businesses to monitor the data from a statistical perspective and provide a virtual access to data across the various study regions.
For instance, specific applications in the wearable device monitor the patient’s heart rate regularly and report them to the researchers automatically. This simplifies the data gathering process for both the patient as well as medical researchers.
Blockchain Developments to Address Patient Privacy Concerns
The privacy of the patient’s data and health information plays a significant role in this developed environment. With patient data piling up, healthcare facilities generally face an issue of data privacy and protection. Blockchain is one of the modern technological developments that is known to handle these circumstances more effectively. By embracing this technology in pharmaceutical companies, patients will have greater control over their data.
To further simplify this procedure, pharmaceutical firms can partner with technology-driven companies. These innovation-driven partnerships have the potential to lower the cyber-attacks and mitigate the risk of clinical trial failure. Top healthcare institutions are planning to adopt this innovation with internal readiness and stay competitive in the dynamic field.
Technology Easing the Direct-to-Patient Strategies
Healthcare professionals can leverage direct-to-patient strategies to interact directly with patients for clinical trials rather than connecting with the mediators. For example, the University of Buffalo’s smartphone application allows patients to evaluate different clinical trials to recognize a good match. Similarly, 23andMe, a prominent genetic testing company, delivers genetic profiling at less than $100 per test. Moreover, this allows every individual participating in a trial to get profiled.
The traditional approach required substantial investment for patient recruitment, clinical site assortment, material procurement tools, etc., without any adequate clarity on its feasibility and success. However, the emergence of technological innovations is helping the professionals in plummeting the time and cost of pre-trial supplies, leading to superior trial competence and output.